Tuesday, September 15, 2026

North Korea Opens Beach Resort, Then Says: No Foreign Tourists

North Korea halts foreign tourism at the Wonsan-Kalman area, citing unspecified reasons despite recent promotion and initial visitor arrivals.

SK Hynix and Samsung’s Q2 Earnings: What to Expect from AI Semiconductor Leaders

Tech giants Samsung and SK Hynix reveal Q2 earnings amid AI chip demand, while U.S. firms Microsoft and Apple follow suit.

Trump’s Demands: How 7 Nations Must Respond to U.S. Military Pressure in the Middle East

Trump pressures allies for military support in the Strait of Hormuz, raising concerns about his aggressive diplomatic tactics.

News1

Author's Latest

“Second-Half Performance to Outpace First Half”… Celltrion Expected to Exceed Full-Year Revenue Target

Celltrion is expected to outperform its first-half results in the second half, driven by new-product growth, European tender wins and stronger demand for high-margin products, potentially allowing it to exceed its full-year targets.

South Korea Begins Its First Advanced Regenerative Medicine Treatment Using ViGenCell Therapy

ViGenCell’s VT-EBV-N has begun South Korea’s first approved advanced regenerative medicine treatment, giving patients with high-risk EBV-positive lymphoma access to a personalized T-cell therapy while generating real-world clinical and manufacturing data.

Unlocking the Future: How Ericsson’s AI-RAN and ISAC Technologies Are Shaping 6G Networks

Ericsson unveils next-gen network technologies aimed at the AI era, highlighting advancements in global telecommunications.

Discover the Enhanced Master V9 2027: 29 Massage Modes for Ultimate Spine Care

Ceragem has launched the Master V9 2027, expanding massage modes to 29 and enhancing heat, reclining features, and usability.

Revolutionizing Kidney Stone Surgery: How the AI-Powered Zamenix Robot Enhances Patient Safety

ROEN surgical has received regulatory approval for its AI-based kidney stone surgery robot Zamenix and related devices.

JNP Medi’s Maven Converter Nominated for Prix Galien Korea 2026: A Game-Changer in Clinical Trials?

JNP Medi's Maven Converter has been nominated for the Prix Galien Korea 2026, the first global pharma and biotech awards in Korea.

Revolutionary Liver Cancer Treatment: How Rivoceranib + Camrelizumab Outperforms Sorafenib in Young Patients

HLB's liver cancer drug combo shows consistent efficacy across all age groups.

How Kangstem Biotech’s Organoid Technology is Revolutionizing Skin Disease Treatment with Global Pharma Partnerships

Kangstem Biotech accelerates global expansion by signing a drug evaluation contract with a major pharmaceutical company for skin immune diseases.

Revolutionizing Knee Treatment: How MIUChon iPSC Therapy Could Replace Joint Surgery by 2026

iPSC-based company YiPSCELL accelerates clinical trials for cartilage cell treatment MIUChon, aiming for new options before joint surgery.

GC Biopharma Leads Innovation in Cancer Treatment with AI-Powered mRNA Platform

Moderna's recent success in personalized cancer vaccine trials highlights the growing interest in mRNA technology.

Samsung Display Unveils Game-Changing Low-Power OLED Technology for Laptops in 2026

Samsung Display is developing new low-power OLED technology for laptops, enhancing energy efficiency and performance.

How Samsung’s 256MB DRAM Revolutionized the Semiconductor Industry in 1994

On August 29, 1994, Samsung announced the successful development of the world's first 256MB DRAM at its Giheung research facility.

Genesis GV90 Neolun: The Revolutionary Coach Door Technology That Redefines Luxury SUVs

The Neolun's coach door, a marvel of advanced technology, signifies a new evolution, showcasing Genesis's ability to realize dreams.

Daewoong Pharmaceutical Wins Seoul Biohealth Award: How Open Innovation is Transforming R&D in 2026

Daewoong Pharmaceutical received recognition for its R&D and open innovation collaboration at the 1st Seoul Biohealth Awards.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.